Pub. Date : 2010 Jun
PMID : 20525481
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Sorafenib, a BRAF inhibitor, has a cytostatic effect on most melanomas with mutations affecting the mitogen-activated protein kinase (MAPK) pathway, and is also capable of triggering apoptosis in a small subgroup of these melanomas. | Sorafenib | B-Raf proto-oncogene, serine/threonine kinase | Homo sapiens |